TA

Therapeutic Advances in Infectious Disease

Therapeutic Advances in Infectious Disease is a peer-reviewed, open access journal focused on pioneering efforts and innovative studies across all areas of infectious disease and related disciplines, including infection control and prevention.

Looking to publish in Therapeutic Advances in Infectious Disease? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Infectious Diseases
Impact Factor 3.4
Quartile Q2
Open Access Type Open
ISSN 2049-9361
eISSN 2049-937X
Invitation Only No
Cost Range Standard APC: $3000 USD; Patient Perspectives, Editorials, and Letters to the Editor: free of charge; Plain Language Summary of Publications (PLS-Ps): $5000.

Submission Instructions

Therapeutic Advances in Infectious Disease accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover letter is required. Cover letter must indicate why the manuscript is suitable for publication and disclose any third-party writing or editing assistance or submission made by a non-author on behalf of the authors.
Abstract Abstract is required. Structured abstract must not exceed 300 words. Abstract must be structured. Abstract must use the headings Background, Objectives, Design, Methods, Results, Conclusion, and Registration (if applicable).
Manuscript Manuscript is recommended to be up to 6000 words excluding tables, figure legends, and references. Include at least 2 keywords after the abstract, an Author Contributions section after the Acknowledgements, and a Statements and Declarations section with all required subheadings at the end of the article.
References There is no limit on references. References must follow Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and every reference list entry must be cited in the text.
Figures & Tables There is no limit on figures and tables. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Review Articles

Cover Letter A cover letter is required. Cover letter must indicate why the manuscript is suitable for publication and disclose any third-party writing or editing assistance or submission made on behalf of the authors by a non-author.
Abstract An abstract is required. Abstract must be unstructured and no more than 300 words. Abstract must be unstructured.
Manuscript Manuscript is recommended to be around 4000–6000 words excluding tables, figure legends and references. Manuscript must include clear heading levels and sections clearly defined, with Acknowledgements followed by Author Contributions and a 'Statements and Declarations' section at the end of the article. Include a minimum of 2 keywords after the abstract, and include each required subheading within the 'Statements and Declarations' section even if marked 'Not applicable'.
References There is no limit on references. References must follow Sage Vancouver style. Every in-text citation must have a corresponding citation in the reference list and every reference list entry must be cited in the text.
Figures & Tables There is no limit on figures and tables. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Systematic Reviews

Cover Letter Cover letter is required. Cover letter must indicate why the manuscript is suitable for publication and disclose any third-party writing or editing assistance or submission made by a non-author on behalf of the authors.
Abstract Abstract is required. Structured abstract must not exceed 300 words. Abstract must be structured. Abstract headings must be Background; Objectives; Design; Data Sources and Methods; Results; Conclusion; Registration (if applicable).
Manuscript Manuscript is recommended to be around 4000–6000 words excluding tables, figure legends and references. Include at least 2 keywords after the abstract and include Author Contributions and a section headed 'Statements and Declarations' after the Acknowledgements section.
References There is no limit on references. References must follow Sage Vancouver style. Every in-text citation must have a corresponding citation in the reference list and vice versa.
Figures & Tables There is no limit on figures and tables. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Meta-Analyses

Cover Letter Cover letter is required and must indicate why the manuscript is suitable for publication. Cover letter must explain why the manuscript is suitable for publication and disclose any third-party writing or editing assistance or submission by a non-author on behalf of the authors.
Abstract Abstract is required. Structured abstract must be no more than 300 words. Abstract must be structured. Abstract headings must be Background; Objectives; Design; Data Sources and Methods; Results; Conclusion; Registration (if applicable).
Manuscript Manuscript is recommended to be around 4000–6000 words excluding tables, figure legends and references. Include a minimum of 2 keywords after the abstract, an Author Contributions section after the Acknowledgements, and a section headed 'Statements and Declarations' at the end of the article with each required subheading included and marked 'Not applicable' when relevant.
References There is no limit on references. References must follow Sage Vancouver style. Every in-text citation must have a corresponding citation in the reference list and every reference list entry must be cited in the text.
Figures & Tables There is no limit on figures and tables. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Scoping Reviews

Cover Letter Cover letter is required. Cover letter must indicate why the manuscript is suitable for publication and disclose any third-party writing or editing assistance or submission by a non-author on behalf of the authors.
Abstract Abstract is required. Structured abstract must not exceed 300 words. Abstract must be structured. Abstract headings must be Background; Objectives; Eligibility Criteria; Sources of Evidence; Charting Methods; Results; and Conclusions.
Manuscript Manuscript is recommended to be around 4000–6000 words excluding tables, figure legends and references. Manuscript must be identified as a scoping review in the title. Include a minimum of 2 keywords after the abstract, an Author Contributions section after the Acknowledgements, and a section headed 'Statements and Declarations' at the end of the article.
References There is no limit on references. References must follow the Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and every reference list entry must be cited in the text.
Figures & Tables There is no limit on figures and tables. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Case Reports

Cover Letter A cover letter is required. Cover letter must indicate why the manuscript is suitable for publication and disclose any third-party writing or editing assistance or submission by a non-author on behalf of the authors.
Abstract An abstract is required. Abstract must be unstructured and no more than 300 words. Abstract must be unstructured.
Manuscript Manuscript is recommended to be up to 2500 words excluding tables, figure legends and references. Include at least 2 keywords after the abstract and include Acknowledgements, Author Contributions, and a 'Statements and Declarations' section with all required subheadings, using 'Not applicable' where needed.
References There is no limit on references. References must follow Sage Vancouver style. Every in-text citation must have a corresponding citation in the reference list and every reference list entry must be cited in the text.
Figures & Tables There is no limit on figures and tables. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Case Series

Cover Letter Cover letter is required. Cover letter must explain why the manuscript is suitable for publication and disclose any third-party writing or editing assistance or submission by someone not listed as an author.
Abstract Abstract is required. Abstract must be unstructured and no more than 300 words. Abstract must be unstructured.
Manuscript Manuscript is recommended to be up to 6000 words excluding tables, figure legends and references. Manuscript must include clear heading levels and clearly defined sections. Manuscript should include at least 2 keywords after the abstract, an Author Contributions section after the Acknowledgements, and a section headed 'Statements and Declarations' with all required subheadings, including 'Not applicable' where relevant.
References References have no limit. References must follow Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and every reference list entry must be cited in the text.
Figures & Tables Figures and tables have no limit. Figures must be numbered consecutively in the order they appear in the text.
Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Brief Reports

Cover Letter Cover letter is required. Cover letter must indicate why the manuscript is suitable for publication and disclose any third-party writing or editing assistance or submission by a non-author on behalf of the authors.
Abstract Abstract is required. Abstract must be structured and must not exceed 150 words. Abstract must be structured. Abstract headings must be Background; Objectives; Design; Methods; Results; Conclusion.
Manuscript Manuscript must be up to 2000 words excluding tables, figure legends and references. Manuscript must state in the Methods section which reporting guidelines were consulted when preparing it. Include at least 2 keywords after the abstract, an Author Contributions section after the Acknowledgements, and a Statements and Declarations section with each required subheading even if marked 'Not applicable'.
References References are limited to a maximum of 20. References must follow Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and every reference list entry must be cited in the text.
Figures & Tables A maximum of 2 figures and tables combined is permitted. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Letters To The Editor

Cover Letter A cover letter is required. Cover letter must indicate why the manuscript is suitable for publication and disclose any third-party writing or editing assistance or submission by a non-author on behalf of the authors.
Abstract Abstract must not be included.
Manuscript Letters to the Editor are recommended to be up to 500 words excluding references. Letters to the Editor must not include a plain language summary, and the manuscript must include at least 2 keywords after the abstract, an Author Contributions heading, and a Statements and Declarations section with all required subheadings.
References References must not exceed 10. References must follow Sage Vancouver style. Every in-text citation must have a corresponding citation in the reference list and vice versa.
Figures & Tables Letters to the Editor are limited to one figure or one table. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Recent Publications

Proceedings from Group B Strep in Pregnancy & Babies Conference, Wednesday 20 May 2026, virtual meeting

-

10.1177/20499361261488501
View Publication

Multidrug-resistant Candida auris osteomyelitis treated with fosmanogepix and surgical source control: A report of a case with favorable outcome

Haitham Alaithan, Alejandro Granillo

10.1177/20499361261499196
View Publication

Clinical characteristics, antimicrobial susceptibility patterns, and mortality predictors in patients with Pseudomonas aeruginosa urinary tract infection: A retrospective study

Faris Abushamma, Shahed Omareyah, Nagham Rashed, Masa Shayib, Masa Hamarsheh, Banan M. Aiesh, Adham Abu Taha, Hammam Abdalrazeq, Dima Malhis, Sa’ed H. Zyoud, Rola Abu Alwafa

10.1177/20499361261493832
View Publication

Histoplasmosis in Uganda: A fungal infection hidden behind tuberculosis, and a diagnostic pathway for a low-resource setting: A narrative review

Kaweesi Calvin Nantalaga, Alice Nantege

10.1177/20499361261498076
View Publication

Occult Candida tropicalis spondylodiscitis following severe polytrauma: A case report and literature review

Yipeng Fang, Ying Gao, Keliang Xie

10.1177/20499361261498077
View Publication

Frequently asked questions

How long does it take to publish?

Articles can appear online within an average of 30 days after acceptance once the APC has been processed.

Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Is a cover letter required?

A cover letter is required. It should indicate why the manuscript is suitable for publication. Writing assistance or third-party submission details must also be stated in the covering letter when applicable.

Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

What are the publication costs?

The standard article processing charge (APC) is $3000 USD, payable after acceptance and before publication. Patient Perspectives, Editorials, and Letters to the Editor are free of charge. Plain Language Summary of Publications (PLS-Ps) have an APC of $5000.

Reformat to Therapeutic Advances in Infectious Disease using Livewrite Premium

Research Topics

Antifungal resistance and susceptibility HIV/AIDS Research and Interventions Fungal Infections and Studies Bacterial Identification and Susceptibility Testing Antimicrobial Resistance in Staphylococcus Tuberculosis Research and Epidemiology Antibiotics Pharmacokinetics and Efficacy Pneumocystis jirovecii pneumonia detection and treatment Antibiotic Use and Resistance HIV, Drug Use, Sexual Risk COVID-19 Clinical Research Studies Pneumonia and Respiratory Infections HIV/AIDS drug development and treatment Antibiotic Resistance in Bacteria Streptococcal Infections and Treatments SARS-CoV-2 and COVID-19 Research Infective Endocarditis Diagnosis and Management Urinary Tract Infections Management Long-Term Effects of COVID-19 Hepatitis C virus research Adolescent Sexual and Reproductive Health Parasites and Host Interactions Clostridium difficile and Clostridium perfringens research Respiratory viral infections research Infectious Diseases and Tuberculosis

Related Journals

JO
Journal of Multimorbidity and Comorbidity SAGE Publishing
CM
Clinical Microbiology and Infection Elsevier BV
JO
Journal of Dental Research SAGE Publishing
SI
Seminars in Cardiothoracic and Vascular Anesthesia SAGE Publishing
DH
Digital Health SAGE Publishing
TA
Therapeutic Advances in Endocrinology and Metabolism SAGE Publishing